Literature DB >> 7993911

Comparison of crystal structures of two homologous proteins: structural origin of altered domain interactions in immunoglobulin light-chain dimers.

D B Huang1, C H Chang, C Ainsworth, A T Brünger, M Eulitz, A Solomon, F J Stevens, M Schiffer.   

Abstract

The sequence and structure of a second human kappa 1 immunoglobulin light-chain variable domain, Wat, has been determined. The R-factor is 15.7% for 1.9-A data. One hundred and ninety-five water molecules were identified; 30 water molecules were located in identical positions in each of the monomers. Some of the water molecules are integral parts of the domains. This light chain is encoded by the same variable domain gene that encoded the previously characterized kappa I variable domain, Rei. Due to limited somatic mutation, the two highly homologous proteins differ in only 20 of the 108 residues. Wat crystallized in space group P6(4) while Rei crystallized in space group P6(1); in both crystals, the asymmetric unit was the noncovalent dimer. Although the basic domain structure is the same for both proteins, the relative positions of the domains within the two dimers differ. This difference is most likely accounted for by the replacement of Tyr36 in Rei by Phe in the Wat protein. Residue Tyr36 is part of the hydrogen-bonding network in the interface between the domains in Rei. Losing the hydrogen-bonding capability of residue 36 by replacement of Tyr by Phe alters the network of hydrogen bonds between the domains, resulting in a different domain-domain contact. The details of lattice contacts in the two crystals were compared. One type of contact that extends the beta-sheet of the individual domains was conserved, but because it involved different symmetry elements within the crystal, different crystal packing resulted. In the Wat crystal, one of the contacts shows an example of how a symmetrical binding site can "bind" an asymmetrical object. Further, the examination of the Wat crystal also illustrates how the different crystalline environments of the domains of the dimer results in different distributions of temperature factors for the residues within the domains.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7993911     DOI: 10.1021/bi00253a024

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Structural relationship of kappa-type light chains with AL amyloidosis: multiple deletions found in a VkappaIV protein.

Authors:  M A Alim; S Yamaki; M S Hossain; K Takeda; M Kozima; T Izumi; I Takashi; T Shinoda
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  Change in dimerization mode by removal of a single unsatisfied polar residue located at the interface.

Authors:  P R Pokkuluri; X Cai; G Johnson; F J Stevens; M Schiffer
Journal:  Protein Sci       Date:  2000-09       Impact factor: 6.725

3.  Altered dimer interface decreases stability in an amyloidogenic protein.

Authors:  Elizabeth M Baden; Barbara A L Owen; Francis C Peterson; Brian F Volkman; Marina Ramirez-Alvarado; James R Thompson
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

Review 4.  Molecular anatomy and the pathological expression of antibody light chains.

Authors:  M Schiffer
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

5.  Tertiary structure of an amyloid immunoglobulin light chain protein: a proposed model for amyloid fibril formation.

Authors:  N Schormann; J R Murrell; J J Liepnieks; M D Benson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

6.  A single mutation promotes amyloidogenicity through a highly promiscuous dimer interface.

Authors:  Francis C Peterson; Elizabeth M Baden; Barbara A L Owen; Brian F Volkman; Marina Ramirez-Alvarado
Journal:  Structure       Date:  2010-05-12       Impact factor: 5.006

Review 7.  Amyloid formation in light chain amyloidosis.

Authors:  Marina Ramirez-Alvarado
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

8.  Light chain amyloidosis - current findings and future prospects.

Authors:  Elizabeth M Baden; Laura A Sikkink; Marina Ramirez-Alvarado
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

9.  Structural alterations within native amyloidogenic immunoglobulin light chains.

Authors:  Edward G Randles; James R Thompson; Douglas J Martin; Marina Ramirez-Alvarado
Journal:  J Mol Biol       Date:  2009-04-08       Impact factor: 5.469

10.  Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light-chain amyloid proteins.

Authors:  P W Stevens; R Raffen; D K Hanson; Y L Deng; M Berrios-Hammond; F A Westholm; C Murphy; M Eulitz; R Wetzel; A Solomon
Journal:  Protein Sci       Date:  1995-03       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.